Summary
The Syst-Eur Trial is a concerted action of the European Community’s Medical and Health Research Programme. The trial is carried out in consultation with the World Health Organization, the International Society of Hypertension, the European Society of Hypertension and the World Hypertension League. This article describes the objectives and the protocol of Syst-Eur, a multicentre trial designed by the European Working Party on High Blood. Pressure in the Elderly (EWPHE), to test the hypothesis that antihypertensive treatment of elderly patients with isolated systolic hypertension results in a significant change in stroke morbidity and mortality. Secondary endpoints include cardiovascular events, such as myocardial infarction and congestive heart failure.
To be eligible patients must be at least 60 years old and have a systolic blood pressure averaging 160–219 mmHg with a diastolic pressure less than 95 mmHg. Patients must give their informed consent and be free of major cardiovascular and non-cardiovascular diseases at entry. The patients are randomized to active treatment or placebo. Active treatment consists of nitrendipine (10–40 mg/day), combined with enalapril (5–20 mg/day) and hydrochlorothiazide (12.5–25 mg/day), as necessary. The patients of the control group receive matching placebos. The drugs (or matching placebos) are stepwise titrated and combined in order to reduce systolic blood pressure by 20 mmHg at least to a level below 150 mmHg. Morbidity and mortality are monitored to enable an intention-to-treat and perprotocol comparison of the outcome in the 2 treatment groups.
A one-year pilot trial (1989) showed that the protocol is practicable. The Ethics Committee therefore decided to start the definite study (1990), in which randomized patients will be followed for 5 years. Recruitment of new centres and of the required 3,000 patients will last 3 years (until 1993).
Similar content being viewed by others
References
European Working Party on High Blood Pressure in the Elderly (EWPHE): An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. Arch. Int. Pharmacodyn. Ther. 275: 300–334, 1985.
Amery A., Birkenhäger W., Brixko P., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F., Forte J., Hamdy R., Henry J.F., Joossens J.V., Leonetti G., Lund-Johansen P., O’Malley K., Petrie J., Strasser T., Tuomilehto J., Williams B.: Mortality and morbidity results from the European Working Party on high blood pressure in the Elderly Trial. Lancet I: 1349–1354, 1985.
Amery A., Birkenhäger W., Brixko P., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F., Forte J., Hamdy R., Henry J.F., Joossens J.V., Leonetti G., Lund-Johansen P., O’Malley K., Petrie J.C., Strasser T., Tuomilehto J., Williams B.: Efficacy of antihypertensive drug treatment according to age, sex, blood pressure and previous cardiovascular disease in patients above the age of 60. Lancet II: 589–592, 1986.
Coope J., Warrender T.S.: Randomized trial of treatment of hypertension in elderly patients in primary care. Br. Med. J. 293: 1145–1151, 1986.
Kuramoto K., Matsushita S., Kuwajima I., Murakawi M.: Prospective study on the treatment of mild hypertension in the aged. Jpn. Heart J. 22: 75–85, 1981.
Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race-sex and age. JAMA 242: 2572–2577, 1979.
Management Committee: Treatment of mild hypertension in the elderly. A study initiated and administered by the National Heart Foundation of Australia. Med. J. Aust. 2: 398–402, 1981.
Staessen J., Fagard R., Van Hoof R., Amery A.: Mortality in various intervention trials in elderly hypertensive patients: a review. Eur. Heart J. 9: 215–222, 1988.
Kannel W.B., Gordon T.: Evaluation of cardiovascular risk in the elderly: the Framingham Study. Bull. N.Y. Acad. Med. 54: 573–591, 1978.
Staessen J., Bulpitt C., Fagard R., Joossens J.V., Lijnen P., Amery A.: Four urinary cations and blood pressure: a population study in two Belgian towns. Am. J. Epidemiol. 117: 676–687, 1983.
M’Buyamba-Kabangu J.R., Fagard R., Lijnen P., Mbuy wa Mbuy R., Staessen J., Amery A.: Blood pressure and urinary cations in urban Bantu of Zaire. Am. J. Epidemiol. 124: 957–968, 1986.
Staessen J., Amery A., Fagard R.: Editorial review: isolated systolic hypertension in the elderly. J. Hypertension 8: 393–405, 1990.
Kannel W.B., Gordon T., Schwartz M.J.: Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham Study. Am. J. Cardiol. 27: 335–346, 1971.
Kannel W.B., Dawber T.R., Sorlie P., Wolf P.A.: Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham Study. Stroke 7: 327–331, 1976.
Rabkin S.W., Mathewson F.A., Tate R.B.: Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures. Ann. Intern. Med. 88: 342–345, 1978.
O’Malley K., McCormack P., O’Brien E.T.: Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. J. Hypertension 6 (suppl. 1): S105–S108, 1988.
Menotti A., Seccareccia F., Giampaolo S., Giuli B.: The predictive role of systolic, diastolic and mean blood pressure on cardiovascular and all causes death. J. Hypertension 7: 595–599, 1989.
Ueda K., Omae T., Hasuo Y., Kiyohara Y.: Impact of high blood pressure on morbidity and mortality. In: Amery A., Staessen J. (Eds.), Handbook of Hypertension. Hypertension in the Elderly, Vol. 12. Elsevier, Amsterdam, 1989, pp. 174–185.
Petrie J.C., O’Brien E.T., Littler W.A., de Swiet M.: Blood pressure measurement. British Medical Journal, London, 1987.
Katz S., Down T.D., Cash H.R., Grotz R.C.: Gerontologist 1: 20–30, 1970.
Keith N.M., Wagener H.P., Barker N.W.: Some different types of essential hypertension: their course and prognosis. Am. J. Med. Sci. 197: 332–343, 1939.
Pipberger H.V., Artsbaecher R.E., Berson A.S.: Recommendations for standardization of leads and of specifications for instruments in electrocardiography and vectorcardiography. American Heart Association Committee on Electrocardiography. Circulation 52: 11–31, 1975.
World Health Organization: Arterial Hypertension. Report of a WHO Expert Committee. World Health Organization Technical Report Series 628, Geneva, 1978.
Kendall M.J., Lobo J., Jack D.B., Main A.N.H.: The influence of age on the pharmacokinetics of nitrendipine. J. Cardiovasc. Pharmacol. 9 (Suppl. 4): S96–S100, 1987.
Lettieri J., Krol G., Yeh S., Ryan J., Jain A., McMahon F.G., Burkholder D., Birkett J.P.: Pharmacokinetics of nitrenidipine in elderly and young healthy volunteers. J. Cardiovasc. Pharmacol. 9 (Suppl. 4): S142–S147, 1987.
Ferreira-Filho S.R., Saragoça M.A., Oliveira P.C., Moriguti J., Ajzen H., Ramos O.L.: Use of nitrendipine in the treatment of systolic hypertension in elderly patients. J. Cardiovasc. Pharmacol. 9 (Suppl. 4): S218–S220, 1987.
Borzellino M., Homes G., Finizola A., Graterol S., Kobelt R., Rojas Z., Rodriguez I.E., Rodriguez E., Finizola B.: Nitrendipine in elderly hypertensives. J. Cardiovasc. Pharmacol. 9 (Suppl 4): S290–S294, 1987.
Hulthén U.L., Katzman P.L.: Review of long-term trials with nitrendipine. J. Cardiovasc. Pharmacol. 12 (Suppl. 4): S11–S15, 1988.
Davies R.O., Irvin J.D., Kramsch D.K., Walker J.F., Moncloa F.: Enalapril worldwide experience. Am. J. Med. 77: 23–35, 1984.
Moncloa F., Sromovsky J.A., Walker J.F., Davies R.O.: Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety. Drugs 30 (Suppl. 1): 82–89, 1985.
Lees K.R., Reid J.L.: Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment. Clin. Pharmacol. Ther. 41: 597–602, 1987.
Conway J., Lauwers P.: Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 21: 21–27, 1960.
Wikstrand J., Westergren G., Berglund G., Bracchetti D., Van Couter A., Feldstein C.A., Ming K.S., Kuramoto K., Landahl S., Meaney E., Pedersen E.B., Rahn K.H., Shaw J., Smith A., Waal-Manning H.: Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. JAMA 255: 1304–1310, 1986.
World Health Organization: International Classification of Diseases, 1975 Revision. Vol. 1, Geneva 1978.
Aho K., Harmsen P., Hatano S., Marquardsen J., Smirnov V.E.: Cerebrovascular disease in the community: results of a WHO collaborative study. Bull. WHO 58: 113–130, 1980.
Genton E., Barnett H.J.M., Fields W.S., et al.: Cerebral ischemia: the role of thrombosis and antithrombotic therapy. Joint Committee for Stroke Resources. Stroke 8: 147, 1977.
Heyman A., Leviton A., Millikan C.H., Nefzger M.D., Ostfeld A.M., Sahs A.L., Stallones A.R., Whisnant J.P.: Transient focal cerebral ischemia: epidemiological and clinical aspects. Stroke 5: 277–287, 1977.
Rose G.A., Blackburn H.: Méthodes d’enquête sur les maladies cardio-vasculaires. Organisation mondiale de la Santé. Genève, 1969.
Pocock S.J.: Group sequential methods in the design and analysis of clinical trials. Biometrika 64: 191–199, 1977.
O’Brien P.C., Fleming T.R.: A multiple testing procedure for clinical trials. Biometrics 35: 549–556, 1979.
Staessen J., Fagard R., Lijnen P., Van Hoof R., Amery A.: Review of the major intervention trials in the elderly. Cardiovasc. Drugs Ther. 4: 1237–1242, 1990.
Kannel W.B., Dawber T.R., McGee D.L.: Perspectives on systolic hypertension: the Framingham Study. Circulation 61: 1179–1182, 1980.
Kannel W.B., Wolf P.A., McGee D.L., Dawber T.R., McNamara P., Castelli W.P.: Systolic pressure, arterial rigidity, and risk of stroke. JAMA 245: 1225–1229, 1981.
Garland C., Barret-Connor E., Suarez L., Criqui M.H.: Isolated systolic hypertension and mortality after age 60 years: a prospective population-based study. Am. J. Epidemiol. 118: 365–376, 1983.
Colandrea M.A., Friedman G.D., Nichaman M.Z., Lynd C.N.: Systolic hypertension in the elderly. An epidemiologic assessment. Circulation 41: 239–245, 1970.
Dyer A.R., Stamler J., Shekelle R.B., Schoenberger J.A., Farinaro E.: Hypertension in the elderly. Med. Clin. North Am. 61: 513–529, 1977.
Curb D.J., Borhani N.O., Entwisle G., Tung B., Kass E., Schnaper H., Williams W., Berman: Isolated systolic hypertension in 14 communities. Am. J. Epidemiol. 121: 362–370, 1985.
McClellan W., Hall W.D., Brogan D., Martinez B., Wilber J.A.: Isolated systolic hypertension: declining prevalence in the elderly. Prev. Med. 16: 686–695, 1987.
Rutan G.H., Kuller L.H., Neaton J.D., Wentworth D.N., McDonald R.H., McFate Smith W.: Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 77: 504–514, 1988.
Vogt T.M., Curtis Ireland C., Black D., Camel G., Hughes G.: Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP pilot study. Controlled Clin. Trials 7: 118–133, 1986.
Wing S., Aubert R.E., Hansen J.P., Harnes C.G., Slome C., Tyroler H.A.: Isolated systolic hypertension in Evans county. I. Prevalence and screening considerations. J. Chronic Dis. 35: 735–742, 1982.
Kannel W.B., Wolf P.A., McGee D.L., Dawber T.R., McNamara P., Castelli W.P.: Systolic blood pressure, arterial rigidity, and risk of stroke. JAMA 245: 1225–1229, 1981.
Wilking S.V.B., Belanger A., Kannel W.B., D’Agostino R.B., Steel K.: Determinants of isolated systolic hypertension. JAMA 260: 3451–3455, 1988.
The WHO/ISH (International Society of Hypertension) Mild Hypertension Liaison Committee: 1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Bull. WHO 67: 493–498, 1989.
Davies B.R., Ford C.E., Remington R.D., Stamler R., Hawkins C.M.: The Hypertension Detection and Follow-up Program design: methods, and baseline characteristics and blood pressure response of the study population. Prog. Cardiovasc. Dis. 29 (Suppl. 1): 11–28, 1986.
Folstein M.F., Folstein S.E., McHugh R.P.: “Mini Mental State”. A practical method for grading the cognitive function state of patients for the clinician. J. Psychiatr. Res. 12: 189–198, 1975.
Applegate W., Dismuke E., Runyan J.W. Jr: Treatment of hypertension in the elderly: a time of caution? J. Am. Geriatr. Soc. 32: 21–23, 1984.
The Working Group on Hypertension in the Elderly: Statement on hypertension in the elderly. JAMA 256: 70–74, 1986.
Gifford R.W. Jr: Geriatric hypertension: Chairman’s comments on the NIH Working Group report. Geriatrics 42: 45–50, 1987.
The Joint National Committee: The 1988 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med. 148: 1023–1038, 1988.
McFate-Smith W.: The case for treating hypertension in the elderly. Am. J. Hypertens. 1 (Suppl. 1): 173s–178s, 1988.
Saltzberg S., Stroh J.A., Frishman W.H.: Isolated systolic hypertension in the elderly: pathophysiology and treatment. Med. Clin. North Am. 72: 523–547, 1988.
Breckenridge M.B., Kostis J.B.: Isolated systolic hypertension in the elderly: results of a statewide survey of clinical practice in New Jersey. Am. J. Med. 86: 370–375, 1989.
Schnall C., Weiner J.S.: Clinical evaluation of blood pressure in alcoholics. Q. J. Stud. Alcohol 19: 432–446, 1958.
deVries H.A.: Physiological effects of an exercise training regimen upon men aged 52 to 88. J. Gerontol. 25: 325–336, 1970.
Weber F., Banard R.J., Roy D.: Effects of a high-complex-carbohydrate, low-fat diet and daily exercise on individuals 70 years of age and older. J. Gerontol. 38: 155–161, 1983.
Niarchos A.P., Weinstein D.L., Laragh J.H.: Comparison of the effects of diuretic therapy and low sodium intake in isolated systolic hypertension. Am. J. Med. 77: 1061–1068, 1984.
Seals D.R., Hurley B.F., Hagberg J.M., Schultz J., Linder B.J., Natter L., Ehsani A.A.: Effects of training on systolic time intervals at rest and during isometric exercise in men and women 61 to 64 years old. Am. J. Cardiol. 55: 797–800, 1985.
Posner J.D., Gorman K.M., Klein H.S., Woldow A.: Exercise capacity in the elderly. Am. J. Cardiol. 57: 52C-58C, 1986.
Cunningham D.A., Rechnitzer P.A., Howard J.H., Donner A.P.: Exercise training of men at retirement: a clinical trial. J. Gerontol. 42: 17–23, 1987.
Potter J.F., Beevers G.D.: Non-pharmacological reduction of blood pressure in the elderly. In: Amery A., Staessen J. (Eds.), Handbook of Hypertension. Hypertension in the Elderly, Vol. 12. Elsevier, Amsterdam, 1989, pp. 352–367.
Mattila K., Haavisto M., Rajala S., Heikinheimo R.: Blood pressure and five-year survival in the very old. Br. Med. J. 296: 887–889, 1988.
Staessen J., Bulpitt C., De Leeuw P., Fagard R., Fletcher A., Fqrette F., Leonetti G., Nissinen A., O’Malley K., Tuomilehto J., Webster J., Williams B.O.: Relation between mortality and treated blood pressure in elderly patients with hypertension: report from the European Working Party on High Blood Pressure in the Elderly. Br. Med. J. 298: 1552–1556, 1989.
Forette B., Tortrat D., Wolmark Y.: Cholesterol as risk factor for mortality in elderly women. Lancet I: 868–870, 1989.
Staessen J., Amery A., Birkenhäger W., Bulpitt C., Clement D., de Leeuw P., De Schaepdryver A., Dollery C., Fagard R., Fletcher A., Forette F., Forte J., Henry J.F., Koistinen A., Leonetti G., Nissinen A., O’Brien E., O’Malley K., Pelemans W., Petrie J.C., Strasser T., Terzoli L., Thijs L., Tuomilehto J., Webster J., Williams B.: Is a high serum cholesterol level associated with longer survival in elderly hypertensives? J. Hypertension 8: 755–761, 1990.
Levenson J., Simon A., Maarek B., Totomoukouo J., Gitelman R., Bouthier J., Safar M.: Comparative effects of beta-adrenergic blockade in systolic hypertension according to age. Eur. Heart J. 4 (Suppl. G): 51–54, 1983.
Vardan S., Mookherjee S., Warner R., Smulyan H.: Systolic hypertension in the elderly. Hemodynamic response to long-term thiazide diuretic therapy and its side effects. JAMA 250: 2807–2813, 1983.
Gray D.R., Weber M.A., Drayer J.I.M.: Effects of low-dose antihypertensive therapy in elderly patients with predominant systolic hypertension. J. Gerontol. 38: 302–306, 1983.
Boyles P.W.: Hydrochlorothiazide plus methyldopa in the treatment of isolated systolic hypertension in the elderly. Clin. Ther, 6: 793–799, 1984.
Niarchos A.P., Laragh J.H.: Effects of diuretic therapy in low-normal- and high-renin isolated systolic systemic hypertension. Am. J. Cardiol. 53: 797–801, 1984.
Vaicaitis J.S.: Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension. Clin. Ther. 6: 451–456, 1984.
Hulley S.B., Furberg C.D., Gurland B., McDonald R., Perry H.M., Schnaper H.W., Schoenberger J.A., McFate Smith W., Vogt T.M.: Systolic hypertension in the elderly program (SHEP): antihypertensive efficacy of chlorthalidone. Am, J. Cardiol. 56: 913–920, 1985.
Morledge J.H., Ettinger B., Aranda J., McBarron F., Barra P., Gorwit J., Davidov M.: Isolated systolic hypertension in the elderly. A placebo-controlled, dose-response evaluation of chlorthalidone. J. Am. Geriatr. Soc. 34: 199–206, 1986.
McFate Smith W., Feigal D.W., Furberg C.D., Greenlick M., Kuller L., Perry H.M., Schnaper H.W., Schoenberger J.A.: Use of diuretics in treatment of hypertension in the elderly. Drugs 31 (Suppl. 4): 154–164, 1986.
Shapiro DA, Liss C.L., Walker J.F., Lewis J.L., Lengerich R.A., Irvin J.D.: Enalapril and hydrochlorothiazide as antihypertensive agents in the elderly. J. Cardiovasc. Pharmacol. 10 (Suppl. 7): 5160–162, 1987.
Duchier J., Iannascoli F., Safar M.: Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am. J. Cardiol. 60: 99–102, 1987.
O’Malley K., McCormack P., O’Brien E.T.: Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. J. Hypertension 6 (Suppl. 1):S105–S108, 1988.
Murray G.D., Lesaffre E.: Statistical pitfalls in the analysis of age-related effects in antihypertensive therapy: J. Cardiovasc. Pharmacol. 12 (Suppl. 8): S167–S172, 1988.
Thijs L., Amery A., Birkenhäger W., Bulpitt C.J., Clement D., Dall J., De Leeuw P., De Schaepdryver A., Dollery C., Forette F., Henry J.F., Koistinen A., Leonetti G., Nissinen A., O’Brien E., O’Malley K., Staessen J., Strasser T., Terzoli L., Tuomilehto J., Webster J., Williams B.O., Zanchetti A.: Age-related effects of placebo and active treatment in patients beyond the age of 60 years: the need of a proper control group. J. Hypertension 8: 997–1002, 1990.
Buhler F.R.: Age and pathophysiology-oriented antihypertensive response to calcium antagonists. J. Cardiovasc. Pharmacol. 12 (Suppl. 8): S156–S162, 1988.
Levenson J.A., Safar M.E., Simon A.C., Bouthier J.A., Griener L.: Central and arterial hemodynamic effects of nifedipine (20 mg) in mild to moderate hypertension. Hypertension 5 (Suppl. V): V57–V60, 1983.
Safar M.E., Simon A.C., Levenson J.A., Cazor J.L.: Hemodynamic effects of diltiazem in hypertension. Circ. Res. 52 (Suppl. 1): 169–173, 1983.
Kohno M., Kumada T., Ozaki M.: Evaluation of aortic wall distensibility by aortic pressure-diameter relation: effects of nifedipine on aortic wall. Cardiovasc. Res. 21: 305–312, 1987.
Simon A.C., Levenson J.A., Bouthier J.A.: Comparison of oral MK 412 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. Am. J. Cardiol. 53: 781–785, 1984.
Safar M.E., Laurent S., Bouthier J.A., London G.M.: Comparative effects of captopril and isosorbide dinitrate on the arterial wall of hypertensive human brachial arteries. J. Cardiovasc. Pharmacol. 8: 1257–1261, 1986.
Levy B.I., Michel J.B., Salzmann J.L., Azizi M., Poitevin P., Safar M., Camilleri J.P.: Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ. Res. 63: 227–239, 1988.
Safar M.E.: Editorial review. Pulse pressure in essential hypertension: clinical and therapeutical implications. J. Hypertension 7: 769–776, 1989.
Staessen J., Cattaert A., Fagard R., Lijnen P., Vanhees L., Amery A.: Epidemiology of treated, compared to untreated hypertension. In: Genest J., Kuchel O., Hamet P., Cantin M. (Eds.), Hypertension. McGraw-Hill Book Company, New York, 1983, pp. 1069–1093.
Fletcher A., Amery A., Birkenhager W., Bulpitt C., Clement D., De Leeuw P., Deruyttere M., De Schaepdryver A., Dollery C., Fagard Lund-Johansen P., Nissinen A., O’Brien E., O’Malley K., Pelemans W., Petrie J.C., Staessen J., Strasser T., Terzoli L., Thijs L., Tuomilehto J., Webster J., Williams B.O.: Risks and benefits in the European Working Party on High Blood Pressure in the Elderly Trial. J. Hypertension 9: 225–230, 1990.
Vogt T.M., Curtis Ireland C., Black D., Camel G., Hughes G.: Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP pilot study. Controlled Clin. Trials 7: 118–133, 1986.
Black D.M., Brand R.J., Greenlick M., Hughes G., Smith J., for the SHEP Pilot Research Group: Compliance to treatment for hypertension in elderly patients: the SHEP Pilot Study. J. Gerontol. 42: 552–557, 1987.
Perry Jr. H.M., McDonald R.H., Hulley S.B., McFate-Smith W., Furberg C.D., Greenlick M.R., Kuller L.H., Schnaper H.W., Schoenberger J.A., Vogt T.M.: Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS). J. Hypertension 4 (Suppl. 6): S21–S23, 1986.
Furberg C.D., Black D.M., for the SHEP Research Group: The systolic hypertension in the elderly pilot program: methodological issues. Eur. Heart J. 9: 223–227, 1988.
Perry H.M., Smith W.M., McDonald R.H., Black D., Cutler J.A., Furberg C.D., Greenlick M.R., Kuller L.H., Schnaper H.W., Schoenberger J.A., Vogt T.M., Wolf P.A., Hulley S.B.: Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) Pilot Study. Stroke 20: 4–13, 1989.
Miall W.E., Greenberg G.: Mild hypertension: is there pressure to treat? Cambridge University Press, Cambridge 1987, pp. 153–178.
Dahlöf B., Hansson L., Lindholm L., Schersten B., Wester P.O.: STOP-Hypertension — Preliminary communication from the Pilot Study of the Swedish Trial in Old Patients with Hypertension. J. Hypertension 5 (Suppl. 5): S607–S610, 1987.
Wu Y.K., Lu C.Q., Gao R.C., Yu J.S., Liu G.C.: Nation-wide hypertension screening in China during 1979–1980. Chin. Med. J. 95: 101–108, 1982.
Tao S.C., Zhang X.G., Wang S.Y., Yu X.H., Wu X., Lu C.Q.: Incidence of acute myocardial infarction and stroke in the capital iron and steel region of Beijing, China. Magnesium 1: 144–150, 1982.
Wu Z.S., Hong Z.G., Yao C.H., Chen D.Y., Nan L., Min Z., Wu Y.Y., Wu Y.K.: Sino-Monica-Beijing Study: report of the results between 1983–1985. Chin. Med. J. 100: 611–620, 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amery, A., Birkenhäger, W., Bulpitt, C.J. et al. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization. Aging Clin Exp Res 3, 287–302 (1991). https://doi.org/10.1007/BF03324024
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324024